NCT02413554View on ClinicalTrials.gov

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2015

Conditions
Delirium
Interventions
DRUG

Rivastigmine patch

acetylcholine esterase inhibitor

All Listed Sponsors
lead

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

NCT02413554 - Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia. | Biotech Hunter | Biotech Hunter